NewslettersExtracellular Matrix NewsUncategorizedCTCFL Regulates the PI3K-Akt Pathway and It Is a Target for Personalized Ovarian Cancer TherapyBy Justin.choi - February 8, 2022033The authors used in vitro models to evaluate the transcriptional changes due to the presence of CTCFL, followed by a selection of gene candidates using de novo network enrichment analysis.[npj Systems Biology and Applications] 7992332 {7992332:BBBBBBBB} apa 50 1 171593 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article